Aug 12, 2026 05:13PM
Aug 12, 2026 04:05PM
Aug 6, 2026 08:31AM
Aug 6, 2026 08:30AM
Aug 4, 2026 08:30AM
Jul 29, 2026 08:30AM
May 14, 2026 05:21PM RenovoRx, Inc. (RNXT) Misses Q1 EPS by 1c
May 14, 2026 04:05PM
Apr 29, 2026 08:30AM
Mar 30, 2026 04:05PM
Mar 20, 2026 08:30AM
Dec 1, 2025 08:30AM
Nov 19, 2025 08:30AM
Nov 13, 2025 05:52PM RenovoRx, Inc. (RNXT) Reports In-Line Q3 EPS
Nov 13, 2025 04:05PM
Oct 27, 2025 08:30AM
Aug 14, 2025 05:03PM
Aug 14, 2025 04:05PM
Jul 14, 2025 08:30AM
May 15, 2025 05:54PM
May 15, 2025 04:05PM RenovoRx Reports First Quarter 2025 Financial Results and Business Highlights
May 1, 2025 08:30AM
Apr 1, 2025 08:30AM
Apr 1, 2025 08:30AM
Nov 14, 2024 08:00AM
Dec 21, 2023 08:30AM
Dec 19, 2023 08:30AM
Dec 13, 2023 08:31AM RenovoRx (RNXT) Files New International Patent for Novel Targeted Combination Drug-Delivery Oncology Therapy Platform
Dec 13, 2023 08:31AM
Nov 16, 2023 08:35AM
Nov 16, 2023 08:35AM
Nov 14, 2023 08:30AM
Aug 17, 2023 08:30AM
Jun 29, 2023 08:03AM
Jun 29, 2023 08:00AM RenovoRx Announces New Positive Interim Phase III Data Demonstrating RenovoGemâ„¢ Delays Cancer Progression by Eight Months in Locally Advanced Pancreatic Cancer
Jun 1, 2023 08:30AM
May 25, 2023 08:30AM
May 15, 2023 08:30AM
Apr 14, 2023 08:30AM
Apr 14, 2023 08:30AM
Apr 11, 2023 08:30AM
Mar 30, 2023 08:30AM RenovoRx (RNXT) Reports Positive New Data from Phase III Clinical Trial Interim Analysis
Mar 30, 2023 08:30AM
Mar 8, 2023 08:32AM
Mar 8, 2023 08:30AM
Mar 2, 2023 08:30AM
Nov 14, 2022 08:30AM
Aug 22, 2022 04:10PM
Aug 15, 2022 08:00AM RenovoRx Reports Second Quarter 2022 Financial Results
May 16, 2022 07:30AM

1,218,242 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All